Pharmafile Logo
Pharmafocus logo
Advanced Search

COVID-19

Showing 15 posts of 602 posts found.

moderna_norwood_plant

Moderna up investments to produce 3 billion COVID vaccine doses in 2022

April 29, 2021
COVID-19, Moderna, Vaccine, investment

Moderna have announced it is making new funding commitments to increase supply at its owned and partnered manufacturing facilities, which …

News
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

April 28, 2021
Research and Development COVID-19, covid 19 news, covid-19 news, news roundup, pharma, pharma news

The past week has seen plenty of COVID-19 news continue to roll in: The European Commission has sued AstraZeneca over …

News

COVID Symptom Study app reveals most common vaccine side effects

April 28, 2021
Research and Development COVID-19, Vaccine, data

An analysis of over 600,000 people’s vaccine reports has been published in The Lancet Infectious Diseases journal, in the largest …

News

Single dose of COVID vaccine can cut transmissions in half

April 28, 2021
Research and Development COVID-19, Public Health England, Vaccine

A Public Health England (PHE) study into the Pfizer-BioNTech and Oxford-AstraZeneca vaccines has found that a single dose of either …

News
EU building with flags outside it

European Commission sues AstraZeneca over COVID-19 jab supplies

April 27, 2021
Manufacturing and Production AstraZeneca, AstraZeneca vaccine, COVID-19, EU, European Commission, covid 19 news, covid-19 news, european union, pharma, pharma news

The European Commission (EC) announced yesterday that it was suing AstraZeneca for failing to respect its contract to supply COVID-19 …

News
Top 10 news roundup

Phamafile.com’s top 10 news stories of the week

April 23, 2021
Medical Communications COVID-19, covid 19 news, covid-19 news, news, news roundup, pharma, pharma news

Among our top 10 stories this week: A study has found the Pfizer COVID-19 vaccine to have a significantly reduced …

News

Jubilant’s oral remdesivir formulation shows positive results in human trial

April 22, 2021
COVID-19, Gilead, Jubilant Pharma, covid-19 treatment, pharma, pharma news, remdesivir

Jubilant Pharma has announced the successful completion of studies in human volunteers for their oral formulation of remdesivir – an …

News

UK Company launches COVID-19 neutralisation assay development kit

April 22, 2021
COVID-19

The Native Antigen Company, a supplier of reagents for research into diagnostics and vaccines, have announced the launch of its …

News

Bharat Biotech jab shows 100% efficacy against severe COVID-19

April 22, 2021
COVID-19, India

Indian biopharma company, Bharat Biotech, has reported interim analysis results from the Phase III trial of its COVID-19 vaccine, Covaxin, …

News
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

April 21, 2021
Research and Development COVID-19, COVID-19 vaccine, covid 19 news, covid-19 news, pharma, pharma news

The past week has seen lots of COVID-19 developments; Avacta’s 20-minute COVID test has gained clinical validation, the EMA has …

News

J&J COVID-19 vaccine to resume Europe rollout

April 21, 2021
Research and Development COVID-19, COVID-19 vaccine, J&J, J&J vaccine, JJ, pharma, pharma news

The Johnson & Johnson COVID-19 vaccine will continue its rollout in Europe, following a review from the EMA.

News

UK Government launches COVID-19 Antivirals Taskforce

April 21, 2021
Research and Development COVID-19, UK government

A new Antivirals Taskforce has been launched by the government to identify treatments for UK patients who have been exposed …

News

Adagio raises $336 million to advance COVID-19 antibody

April 20, 2021
Manufacturing and Production Adagio, COVID-19, Financing, covid-19 treatment, pharma, pharma news

Adagio Therapeutics has financed $336 million to support the rapid advancement of their novel ADG20 antibody for the treatment and …

News

Avacta’s COVID-19 lateral flow test gains clinical validation

April 20, 2021
Manufacturing and Production COVID-19

Avacta have announced positive data from the clinical validation of its AffiDX SARS-CoV-2 antigen lateral flow test, based on a …

News
Eli Lilly front sign

Lilly’s COVID-19 drug has EUA revoked in favour of combination therapy

April 19, 2021
Sales and Marketing COVID-19, Eli Lilly, FDA, covid-19 treatment, lilly, pharma, pharma news

The FDA have revoked Emergency Use Authorization (EUA) of Eli Lilly’s bamlanivimab drug for the treatment of COVID-19, per the …

News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026